SYK
64
-4
NDAQ
62
2
NAVI
52
5
DFS
64
2
CAH
48
-5
WM
79
3
KMI
67
-2
FLR
58
3
CHRW
56
-3
CSCO
67
4
ACN
52
3
DTE
56
2
PLD
56
8
EQIX
64
2
LMT
34
2
F
58
11
ORLY
62
2
HCP
66
8
WBA
48
4
LEG
36
4
SYK
64
-4
NDAQ
62
2
NAVI
52
5
DFS
64
2
CAH
48
-5
WM
79
3
KMI
67
-2
FLR
58
3
CHRW
56
-3
CSCO
67
4
ACN
52
3
DTE
56
2
PLD
56
8
EQIX
64
2
LMT
34
2
F
58
11
ORLY
62
2
HCP
66
8
WBA
48
4
LEG
36
4
Financhill
Back

Novo Integrated Sciences 10K Form

Sell
27

NVOS
Novo Integrated Sciences

Last Price:
0.06
Seasonality Move:
7.23%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive NVOS News And Ratings

See the #1 stock for the next 7 days that we like better than NVOS

NVOS Financial Statistics

Sales & Book Value

Annual Sales: $12.57M
Cash Flow: $-660K
Price / Cash Flow: 0
Annual Sales: $0.52
Price / Book: 0.11

Profitability

EPS (TTM): -1.31000
Net Income (TTM): $-24.33M
Gross Margin: $4.95M
Return on Equity: -115.16%
Return on Assets: -68.02%

Novo Integrated Sciences Earnings Forecast

Key Novo Integrated Sciences Financial Ratios

  • The Gross Profit Margin over the past 17 years for NVOS is 39.39%.
  • The Selling, General & Administrative Expenses for NVOS have been equal to 107.43% of Gross Profit Margin.
  • The Interest Expense is -38.73% of Operating Income.
  • The Net Earning history of NVOS is -105.11% of Total Revenues.
  • Per Share Earnings over the last 20 years have been positive in 11 years.

Novo Integrated Sciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Health Care Providers & Services
Sector: Health Care
Current Symbol: NVOS
Website: novointegrated.com

Debt

Debt-to-Equity Ratio: 0.26
Current Ratio: 0.27
Quick Ratio: 0.17

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

NVOS Technical Analysis vs Fundamental Analysis

Sell
27
Novo Integrated Sciences (NVOS) is a Sell

Is Novo Integrated Sciences a Buy or a Sell?